1. Home
  2. NOAH vs MPLT Comparison

NOAH vs MPLT Comparison

Compare NOAH & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NOAH

Noah Holdings Limited

HOLD

Current Price

$11.45

Market Cap

754.2M

Sector

Finance

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$19.37

Market Cap

772.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NOAH
MPLT
Founded
2005
2018
Country
China
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
754.2M
772.7M
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
NOAH
MPLT
Price
$11.45
$19.37
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$10.75
$31.00
AVG Volume (30 Days)
111.4K
172.6K
Earning Date
11-25-2025
02-28-2026
Dividend Yield
5.10%
N/A
EPS Growth
N/A
N/A
EPS
0.93
N/A
Revenue
$355,222,638.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.13
N/A
P/E Ratio
$12.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.67
$12.24
52 Week High
$12.84
$21.55

Technical Indicators

Market Signals
Indicator
NOAH
MPLT
Relative Strength Index (RSI) 65.07 N/A
Support Level $10.97 N/A
Resistance Level $11.36 N/A
Average True Range (ATR) 0.36 0.00
MACD 0.06 0.00
Stochastic Oscillator 81.63 0.00

Price Performance

Historical Comparison
NOAH
MPLT

About NOAH Noah Holdings Limited

Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Share on Social Networks: